Scleroderma in children.
This article discusses the various clinical, laboratory, and therapeutic aspects of systemic sclerosis and localized scleroderma in children. The close collaboration among pediatricians, rheumatologists, and dermatologists represents an important advance in the management of these disabling conditions.
Zulian
Francesco
F
Pediatric Rheumatology Unit, Department of Pediatrics, University of Padova, Via Giustiniani 3 35128, Padua, Italy. zulian@pediatria.unipd.it
D000293:Adolescent; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D002648:Child; D003937:Diagnosis, Differential; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D012595:Scleroderma, Systemic / Q000175:diagnosis* / Q000188:drug therapy / Q000503:physiopathology
D000893:Anti-Inflammatory Agents; D007166:Immunosuppressive Agents